相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The turnover of estrogen receptor α by the selective estrogen receptor degrader (SERD) fulvestrant is a saturable process that is not required for antagonist efficacy
Suzanne E. Wardell et al.
BIOCHEMICAL PHARMACOLOGY (2011)
A Novel Proteomics Approach to Identify SUMOylated Proteins and Their Modification Sites in Human Cells
Frederic Galisson et al.
MOLECULAR & CELLULAR PROTEOMICS (2011)
Structural and Functional Roles of Daxx SIM Phosphorylation in SUMO Para log-Selective Binding and Apoptosis Modulation
Che-Chang Chang et al.
MOLECULAR CELL (2011)
SUMO E3 ligase activity of TRIM proteins
Y. Chu et al.
ONCOGENE (2011)
SnapShot: The SUMO System
Sandrine Creton et al.
CELL (2010)
The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition
Jaclyn R. Gareau et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
PML Nuclear Bodies
Valerie Lallemand-Breitenbach et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Enhanced SUMOylation of proteins containing a SUMO-interacting motif by SUMO-Ubc9 fusion
Eui Tae Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
SUMO association with repressor complexes, emerging routes for transcriptional control
Mario Garcia-Dominguez et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2009)
Identification of four novel phosphorylation sites in estrogen receptor α: impact on receptor-dependent gene expression and phosphorylation by protein kinase CK2
Christopher C. Williams et al.
BMC BIOCHEMISTRY (2009)
Role of SUMO in RNF4-mediated Promyelocytic Leukemia Protein (PML) Degradation SUMOYLATION OF PML AND PHOSPHO-SWITCH CONTROL OF ITS SUMO BINDING DOMAIN DISSECTED IN LIVING CELLS
Yann Percherancier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
SUMOylation Attenuates the Function of PGC-1α
Miia M. Rytinki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Using mass spectrometry to identify ubiquitin and ubiquitin-like protein conjugation sites
Stanley M. Jeram et al.
PROTEOMICS (2009)
FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription
Mathieu Lupien et al.
CELL (2008)
Structure of the Small Ubiquitin-like Modifier (SUMO)-interacting Motif of MBD1-containing Chromatin-associated Factor 1 Bound to SUMO-3
Naotaka Sekiyama et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
SUMOylation modulates the transcription repressor function of RIP140
Miia M. Rytinki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
SUMO-mediated inhibition of glucocorticoid receptor synergistic activity depends on stable assembly at the promoter but not on DAXX
Sam R. Holmstrom et al.
MOLECULAR ENDOCRINOLOGY (2008)
RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation
Michael H. Tatham et al.
NATURE CELL BIOLOGY (2008)
Arsenic degrades PML or PML - RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway
Valerie Lallemand-Breitenbach et al.
NATURE CELL BIOLOGY (2008)
PHD domain-mediated E3 ligase activity directs intramolecular sumoylation of an adjacent bromodomain required for gene silencing
Alexey V. Ivanov et al.
MOLECULAR CELL (2007)
Daxx mediates SUMO-dependent transcriptional control and subnuclear compartmentalization
H. -M. Shih et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
A role for SUMO modification in transcriptional repression and activation
M. J. Lyst et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
SUMOrganization of the nucleus
Patrick Heun
CURRENT OPINION IN CELL BIOLOGY (2007)
Raloxifene and ICI182,780 increase estrogen receptor-α association with a nuclear compartment via overlapping sets of hydrophobic amino acids in activation function 2 helix 12
Mathieu Lupien et al.
MOLECULAR ENDOCRINOLOGY (2007)
Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors
Ding-Yen Lin et al.
MOLECULAR CELL (2006)
Coordinated regulation of AIB1 transcriptional activity by sumoylation and phosphorylation
Huijian Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Tamoxifen and raloxifene differ in their functional interactions with aspartate 351 of estrogen receptor α
Guila Dayan et al.
MOLECULAR PHARMACOLOGY (2006)
Fulvestrant (ICI 182,780)-dependent interacting proteins mediate immobilization and degradation of estrogen receptor-α
XH Long et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
SUMOylation of the corepressor N-CoR modulates its capacity to repress transcription
J Tiefenbach et al.
MOLECULAR BIOLOGY OF THE CELL (2006)
Changes in oestrogen receptor-α and -β during progression to acquired resistance to tamoxifen and fulvestrant (Faslodex, ICI 182,780) in MCF7 human breast cancer cells
L. E. Shaw et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2006)
Nuclear receptor mediated gene regulation through chromatin remodeling and histone modifications
Masahiko Kishimoto et al.
ENDOCRINE JOURNAL (2006)
Ubiquitin and SUMO systems in the regulation of mitotic checkpoints
Gustavo J. Gutierrez et al.
TRENDS IN BIOCHEMICAL SCIENCES (2006)
Sumoylation of the estrogen receptor α hinge region regulates its transcriptional activity
S Sentis et al.
MOLECULAR ENDOCRINOLOGY (2005)
Mutation of SENP1/SuPr-2 reveals an essential role for desumoylation in mouse development
T Yamaguchi et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-α and promoter-specific effects in breast cancer cells deficient in N-CoR and SMRT
EK Keeton et al.
MOLECULAR ENDOCRINOLOGY (2005)
Histone deacetylase inhibition and estrogen receptor α levels modulate the transcriptional activity of partial antiestrogens
R Margueron et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2004)
Selective estrogen receptor modulators:: Discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells
J Frasor et al.
CANCER RESEARCH (2004)
Development and characterization of a cell line that stably expresses an estrogen-responsive luciferase reporter for the detection of estrogen receptor agonist and antagonists
VS Wilson et al.
TOXICOLOGICAL SCIENCES (2004)
SUMO and ubiquitin in the nucleus: different functions, similar mechanisms?
G Gill
GENES & DEVELOPMENT (2004)
Real-time monitoring of ubiquitination in living cells by BRET
J Perroy et al.
NATURE METHODS (2004)
Distinct in vivo dynamics of vertebrate SUMO paralogues
F Ayaydin et al.
MOLECULAR BIOLOGY OF THE CELL (2004)
Mechanisms of tamoxifen resistance: Increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer
J Shou et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Protein modification by SUMO
ES Johnson
ANNUAL REVIEW OF BIOCHEMISTRY (2004)
FHL2, UBC9, and PIAS1 are novel estrogen receptor alpha-interacting proteins
S Kobayashi et al.
ENDOCRINE RESEARCH (2004)
Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor α (ERα), differentially affect ERα extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells
V Marsaud et al.
MOLECULAR ENDOCRINOLOGY (2003)
Nuclear and unclear functions of SUMO
JS Seeler et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Full activation of estrogen receptor α activation function-1 induces proliferation of breast cancer cells
T Fujita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Cyclic, proteasome-mediated turnover of unliganded and liganded ERα on responsive promoters is an integral feature of estrogen signaling
G Reid et al.
MOLECULAR CELL (2003)
Differential SERM effects on corepressor binding dictate ERα activity in vivo
P Webb et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The nuclear receptor superfamily
M Robinson-Rechavi et al.
JOURNAL OF CELL SCIENCE (2003)
Modification with SUMO - A role in transcriptional regulation
A Verger et al.
EMBO REPORTS (2003)
SUMO: ligases, isopeptidases and nuclear pores
F Melchior et al.
TRENDS IN BIOCHEMICAL SCIENCES (2003)
17 beta-estradiol- and 4-hydroxytamoxifen-induced transactivation in breast, endometrial and liver cancer cells is dependent on ER-subtype, cell and promoter context
E Castro-Rivera et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2003)
Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor
S Tian et al.
BIOCHEMICAL JOURNAL (2002)
PIAS1 and PIASxα function as SUMO-E3 ligases toward androgen receptor and repress androgen receptor-dependent transcription
T Nishida et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Two antiestrogens affect differently chromatin remodeling of trefoil factor 1 (pS2) gene and the fate of estrogen receptor in MCF7 cells
C Giamarchi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2002)
The inhibitory function in human progesterone receptor N termini binds SUMO-1 protein to regulate autoinhibition and transrepression
H Abdel-Hafiz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Potentiation of glucocorticoid receptor transcriptional activity by sumoylation
Y Le Drean et al.
ENDOCRINOLOGY (2002)
Molecular determinants for the tissue specificity of SERMs
YF Shang et al.
SCIENCE (2002)
The human estrogen receptor-α is a ubiquitinated protein whose stability is affected differentially by agonists, antagonists, and selective estrogen receptor modulators
AL Wijayaratne et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting
MS Rodriguez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Structural insights into the mode of action of a pure antiestrogen
ACW Pike et al.
STRUCTURE (2001)
Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1)
H Poukka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Covalent modification of p73α by SUMO-1 -: Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif
A Minty et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
